1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Bedside to Bench and Back Again: Understand, Treat and Prevent HSV and VZV Infections"}],["$","meta","1",{"name":"description","content":"NIH Director Elias Zerhouni noted in the New England Journal of Medicine, “Advances in our understanding of biologic systems and development of powerful new tools that can be applied at both the bench and the bedside — genomics, proteomics, transgenic animal models, structural biology, biochemistry and imaging technologies — offer unprecedented prospects for advancing knowledge of human disorders in a translational context. For 28 years, Stephen Straus has been an intramural scientist in NIAID doing bench-to-bedside research. He has achieved an outstanding record as a scientific leader, conducting his own basic, translational, and clinical research. His research interests are in human viral and immunologic diseases, including chronic fatigue syndrome, Lyme disease, AIDS, hepatitis B, genital herpes and chronic post-herpetic pain.\n
\n
\nhttp://www.niaid.nih.gov/dir/labs/LCI/mvs.htm\n
\n
\nWALS"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Bedside to Bench and Back Again: Understand, Treat and Prevent HSV and VZV Infections"}],["$","meta","4",{"property":"og:description","content":"NIH Director Elias Zerhouni noted in the New England Journal of Medicine, “Advances in our understanding of biologic systems and development of powerful new tools that can be applied at both the bench and the bedside — genomics, proteomics, transgenic animal models, structural biology, biochemistry and imaging technologies — offer unprecedented prospects for advancing knowledge of human disorders in a translational context. For 28 years, Stephen Straus has been an intramural scientist in NIAID doing bench-to-bedside research. He has achieved an outstanding record as a scientific leader, conducting his own basic, translational, and clinical research. His research interests are in human viral and immunologic diseases, including chronic fatigue syndrome, Lyme disease, AIDS, hepatitis B, genital herpes and chronic post-herpetic pain.\n
\n
\nhttp://www.niaid.nih.gov/dir/labs/LCI/mvs.htm\n
\n
\nWALS"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/98f8867d-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/fd8098b9-4321-4fce-a93b-e1302086fcb0.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Bedside to Bench and Back Again: Understand, Treat and Prevent HSV and VZV Infections"}],["$","meta","11",{"name":"twitter:description","content":"NIH Director Elias Zerhouni noted in the New England Journal of Medicine, “Advances in our understanding of biologic systems and development of powerful new tools that can be applied at both the bench and the bedside — genomics, proteomics, transgenic animal models, structural biology, biochemistry and imaging technologies — offer unprecedented prospects for advancing knowledge of human disorders in a translational context. For 28 years, Stephen Straus has been an intramural scientist in NIAID doing bench-to-bedside research. He has achieved an outstanding record as a scientific leader, conducting his own basic, translational, and clinical research. His research interests are in human viral and immunologic diseases, including chronic fatigue syndrome, Lyme disease, AIDS, hepatitis B, genital herpes and chronic post-herpetic pain.\n
\n
\nhttp://www.niaid.nih.gov/dir/labs/LCI/mvs.htm\n
\n
\nWALS"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}